BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fraga-Silva TFC, Maruyama SR, Sorgi CA, Russo EMS, Fernandes APM, de Barros Cardoso CR, Faccioli LH, Dias-Baruffi M, Bonato VLD. COVID-19: Integrating the Complexity of Systemic and Pulmonary Immunopathology to Identify Biomarkers for Different Outcomes. Front Immunol 2020;11:599736. [PMID: 33584667 DOI: 10.3389/fimmu.2020.599736] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Madè A, Greco S, Vausort M, Miliotis M, Schordan E, Baksi S, Zhang L, Baryshnikova E, Ranucci M, Cardani R, Fagherazzi G, Ollert M, Tastsoglou S, Vatsellas G, Hatzigeorgiou A, Firat H, Devaux Y, Martelli F. Association of miR-144 levels in the peripheral blood with COVID-19 severity and mortality. Sci Rep 2022;12:20048. [PMID: 36414650 DOI: 10.1038/s41598-022-23922-2] [Reference Citation Analysis]
2 Kim S, Kim J, Jang JY, Noh H, Park J, Jeong H, Jeon D, Uhm C, Oh H, Cho K, Jeon Y, On D, Yoon S, Lim S, Kim SP, Lee YW, Jang HJ, Park IH, Oh J, Seo JS, Kim JJ, Seok S, Lee YJ, Hong S, An S, Kim SY, Kim YB, Hwang J, Lee H, Kim HB, Choi K, Park JW, Seo J, Yun J, Shin J, Lee H, Kim K, Lee D, Lee H, Nam KT, Seong JK. Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1055811] [Reference Citation Analysis]
3 Seliger B, Jasinski-bergner S, Massa C, Mueller A, Biehl K, Yang B, Bachmann M, Jonigk D, Eichhorn P, Hartmann A, Wickenhauser C, Bauer M. Induction of pulmonary HLA-G expression by SARS-CoV-2 infection. Cell Mol Life Sci 2022;79:582. [DOI: 10.1007/s00018-022-04592-9] [Reference Citation Analysis]
4 Cordeiro JFC, Fernandes TM, Toro DM, da Silva-neto PV, Pimentel VE, Pérez MM, de Carvalho JCS, Fraga-silva TFC, Oliveira CNS, Argolo JGM, Degiovani AM, Ostini FM, Puginna EF, da Silva JS, Santos IKFM, Bonato VLD, Cardoso CRB, Dias-baruffi M, Faccioli LH, Donadi EA, Sorgi CA, Fernandes APM; on behalf of the IMMUNOCOVID Study Group. The Severity of COVID-19 Affects the Plasma Soluble Levels of the Immune Checkpoint HLA-G Molecule. IJMS 2022;23:9736. [DOI: 10.3390/ijms23179736] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Fraga-silva TFC, Cipriano UG, Fumagalli MJ, Correa GF, Fuzo CA, Mestriner FLAC, Becari C, Teixeira-carvalho A, Coelho-dos-reis J, Menegueti MG, Figueiredo LTM, Martins-filho OA, Dias-baruffi M, Auxiliadora-martins M, Tostes R, Bonato VLD. Airway epithelial cells and macrophages trigger IL-6-CD95/CD95L axis and mediate initial immunopathology of COVID-19.. [DOI: 10.1101/2022.08.22.504760] [Reference Citation Analysis]
6 Fuzo CA, Martins RB, Fraga-Silva TFC, Amstalden MK, Canassa De Leo T, Souza JP, Lima TM, Faccioli LH, Okamoto DN, Juliano MA, França SC, Juliano L, Bonato VLD, Arruda E, Dias-Baruffi M. Celastrol: A lead compound that inhibits SARS-CoV-2 replication, the activity of viral and human cysteine proteases, and virus-induced IL-6 secretion. Drug Dev Res 2022. [PMID: 35989498 DOI: 10.1002/ddr.21982] [Reference Citation Analysis]
7 da Silva-neto PV, do Valle VB, Fuzo CA, Fernandes TM, Toro DM, Fraga-silva TFC, Basile PA, de Carvalho JCS, Pimentel VE, Pérez MM, Oliveira CNS, Rodrigues LC, Bastos VAF, Tella SOC, Martins RB, Degiovani AM, Ostini FM, Feitosa MR, Parra RS, Vilar FC, Gaspar GG, Rocha JJRD, Feres O, Arruda E, Maruyama SR, Russo EMS, Viana AL, Santos IKFM, Bonato VLD, Cardoso CRB, Tanus-santos JE, Donadi EA, Faccioli LH, Dias-baruffi M, Fernandes APM, Gerlach RF, Sorgi CA; on behalf of the IMMUNOCOVID Study Group. Matrix Metalloproteinases on Severe COVID-19 Lung Disease Pathogenesis: Cooperative Actions of MMP-8/MMP-2 Axis on Immune Response through HLA-G Shedding and Oxidative Stress. Biomolecules 2022;12:604. [DOI: 10.3390/biom12050604] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Torzewski M. C-Reactive Protein: Friend or Foe? Phylogeny From Heavy Metals to Modified Lipoproteins and SARS-CoV-2. Front Cardiovasc Med 2022;9:797116. [DOI: 10.3389/fcvm.2022.797116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Rashidi S, Vieira C, Tuteja R, Mansouri R, Ali-hassanzadeh M, Muro A, Nguewa P, Manzano-román R. Immunomodulatory Potential of Non-Classical HLA-G in Infections including COVID-19 and Parasitic Diseases. Biomolecules 2022;12:257. [DOI: 10.3390/biom12020257] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Gamon E, Tammena D, Wattenberg M, Augenstein T. [Rare superinfection in a COVID-19 patient-A chronology]. Anaesthesist 2021. [PMID: 34427689 DOI: 10.1007/s00101-021-01018-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Al-Bayatee NT, Ad'hiah AH. Soluble HLA-G is upregulated in serum of patients with severe COVID-19. Hum Immunol 2021:S0198-8859(21)00181-6. [PMID: 34304938 DOI: 10.1016/j.humimm.2021.07.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
12 Shi N, Huang C, Zhang Q, Shi C, Liu F, Song F, Hou Q, Shen J, Shan F, Su X, Liu C, Zhang Z, Shi L, Shi Y. Longitudinal trajectories of pneumonia lesions and lymphocyte counts associated with disease severity among convalescent COVID-19 patients: a group-based multi-trajectory analysis. BMC Pulm Med 2021;21:233. [PMID: 34256743 DOI: 10.1186/s12890-021-01592-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Fuzo CA, Martins RB, Fraga-silva TF, Amstalden MK, De Leo TC, Souza JP, Lima TM, Faccioli LH, França SC, Bonato VL, Arruda E, Dias-baruffi M. Drug repurposing to face Covid-19: Celastrol, a potential leading drug capable of inhibiting SARS-CoV-2 replication and induced inflammation.. [DOI: 10.1101/2021.04.20.439992] [Reference Citation Analysis]